Investor profile
Two Bear Capital
VC
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Two Bear Capital invests in founders with breakthrough ideas to solve urgent, complex problems by harnessing life sciences and technology. The firm focuses on disruptive innovations at critical inflection points in biotechnology, bioinformatics, healthcare IT, machine learning & AI, and information security. Two Bear Capital provides early-stage capital and mentorship to turn boot-strapping startups into companies built to endure. Their portfolio companies operate at the intersection of technology and life sciences—often in areas where the two are so seamlessly integrated as to form a new, unified discipline. These are companies that will cure disease, reveal insights hidden in vast quantities of data, and create safer, more efficient networks for individuals and enterprises.
Notable quotes
“Effectively harnessing the incredible power of the human immune system has the potential to prevent or cure the most devastating diseases faced by humanity – from Covid-19, to cancer, to neurodegenerative diseases and more – and the need for solutions today is more urgent than ever. The team at Inimmune combines world-class immunology and vaccine expertise, proven track records and a passion for solving some of the most important medical crises of our time.”
“Two Bear Capital is proud to be leading the seed funding round for Binarly. Binarly's technology platform stands out for its ability to address firmware and software supply chain issues at scale, a critical concern for businesses worldwide.”
Team
J. Seth Strattan
General Partner
Cris Neckar
Partner
Avery Sonnenberg
Partner
Neil White
Partner
Rachel Tsunemoto Hislop
Principal, Director of Research
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Rainfall Health | Series A | — | 2026-02 |
| Selector | Series B | — | 2026-02 |
| Revenium | Seed | — | 2025-11 |
| Gravwell | Series A | — | 2025-10 |
| Conceal | Series B | — | 2025-05 |
| Montara Therapeutics | Seed | $8m | 2024-07 |
| Binarly | Seed | $11m | 2024-03 |
| Elisity | Series B | $45m | 2024-04 |
| TileDB | Series B | $34m | 2023-10 |
| Graphiant | Series B | $62m | 2023-03 |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| WestWave Capital | 4 |
| Canaan Partners | 3 |
| Cisco Investments | 3 |
| Liquid 2 Ventures | 3 |
| BLU Venture Investors | 3 |
| Sequoia Capital | 1 |
Fit check
Is Two Bear Capital a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit